Biotech investors waiting for partnership announcements
Shares of PharmaGap (TSX: V.GAP) rallied 31% to 19 cents on Wednesday.
Micromet soars on new cancer treatment
Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced publication of a Phase 1 clinical study.
